Potential interaction of chemotherapy and gefitinib in the induction of hematologic neoplasia

Saved in:

Bibliographic Details
Published in:	Leukemia Vol. 21; no. 12; pp. 2546 - 2547
Main Authors:	Ravindranathan, M, Klementich, F J, Jones, Jr, D V
Format:	Journal Article
Language:	English
Published:	England Nature Publishing Group 01-12-2007
Subjects:	Adenocarcinoma - drug therapy Adenocarcinoma - radiotherapy Aged Anemia, Refractory - chemically induced Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - pharmacology Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Carboplatin - administration & dosage Carboplatin - adverse effects Carcinoma, Non-Small-Cell Lung - drug therapy Chemotherapy Cisplatin - administration & dosage Cisplatin - adverse effects Combined Modality Therapy Deoxycytidine - administration & dosage Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives Dosage and administration Drug Interactions Drug therapy Gefitinib Genetic aspects Health aspects Hematopoiesis - drug effects Humans Leukemia, Promyelocytic, Acute - chemically induced Lung cancer, Non-small cell Lung Neoplasms - drug therapy Lung Neoplasms - radiotherapy Male Neoplasm Proteins - antagonists & inhibitors Neoplasm Proteins - physiology Neoplasms, Second Primary - chemically induced Protein Kinase Inhibitors - adverse effects Protein Kinase Inhibitors - pharmacology Protein Kinase Inhibitors - therapeutic use Quinazolines - adverse effects Quinazolines - pharmacology Quinazolines - therapeutic use Receptor, Epidermal Growth Factor - antagonists & inhibitors Receptor, Epidermal Growth Factor - physiology United States
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23
ISSN:	0887-6924 1476-5551
DOI:	10.1038/sj.leu.2404851